Skip to main content

Thank you for visiting nature.com. You are using a browser version with limited support for CSS. To obtain the best experience, we recommend you use a more up to date browser (or turn off compatibility mode in Internet Explorer). In the meantime, to ensure continued support, we are displaying the site without styles and JavaScript.

  • Brief Communication
  • Published:

The potentiation activity of β-lactam by phomoidrides and oxasetin against methicillin-resistant Staphylococcus aureus

Abstract

Antimicrobial resistance (AMR) causes a global health threat and enormous damage for humans. Among them, Methicillin-resistant Staphylococcus aureus (MRSA) resistant to first-line therapeutic β-lactam drugs such as meropenem (MEPM) is problematic. Therefore, we focus on combination drug therapy and have been seeking new potentiators of MEPM to combat MRSA. In this paper, we report the isolation of phomoidrides A–D and its new analog, phomoidride H along with a polyketide compound, oxasetin from the culture broth of Neovaginatispora clematidis FKI-8547 strain as potentiators of MEPM against MRSA.

This is a preview of subscription content, access via your institution

Access options

Buy this article

Prices may be subject to local taxes which are calculated during checkout

Fig. 1

References

  1. Antibiotic Resistance Threats in the United States, 2019. Department of Health and Human Services, CDC, 2019, www.cdc.gov/DrugResistance/Biggest-Threats.html.

  2. Murray CJL. Global burden of bacterial antimicrobial resistance in 2019: a systematic analysis. Lancet. 2022;399:629–55.

    Article  CAS  Google Scholar 

  3. Nordmann P, Dortet L, Poirel L. Carbapenem resistance in Enterobacteriaceae: here is the storm! Trends Mol Med. 2012;18:263–72.

    Article  PubMed  CAS  Google Scholar 

  4. Worthington RJ, Melander C. Combination approach to combat multidrug-resistant bacteria. Trends Biotechnol. 2013;31:177–84.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  5. Taba K, Honsho M, Asami Y, Iwasaki H, Nonaka K, Watanabe Y, et al. Synergistic effect of secondary metabolites isolated from Pestalotiopsis sp. FKR-0115 in overcoming β-lactam resistance in MRSA. J Gen Apple Microbiol. 2023. https://doi.org/10.2323/jgam.2023.05.001.

  6. Kanaida M, Kimishima A, Eguchi S, Iwatsuki M, Watanabe Y, Honsho M, et al. Total syntheses and chemical biology studies of Hymeglusin and Fusarilactone A, novel circumventors of β-lactam drug resistance in methicillin-resistant Staphylococcus aureus. Chem Med Chem. 2021;16:2106–11.

    Article  PubMed  CAS  Google Scholar 

  7. Dabrah TT, Harwood HJ, Huang LH, Jankovich ND, Kaneko T, Li JC, et al. CP-225,917 and CP-263,114, novel Ras farnesylation inhibitors from an unidentified fungus. 1. Taxonomy, fermentation, isolation, and biochemical properties. J Antibiot. 1997;50:1–7.

    Article  CAS  Google Scholar 

  8. Dabrah TT, Kaneko T, Massefski W, Whipple EB. CP-225,917 and CP-263,114: novel farnesylation inhibitors from an unidentified fungus. 2. Structure elucidation. J Am Chem Soc. 1997;119:1594–8.

    Article  CAS  Google Scholar 

  9. He H, Janso JE, Singh MP, Bernan VS, Greenstein M, Carter GT. Oxasetin, a new antibacterial polyketide produced by fungus Vaginatispora aquatica, HK1821. J Antibiot. 2002;55:821–5.

    Article  CAS  Google Scholar 

  10. Nonaka K, et al. Staphylotrichum boninense, a new hyphomycete (Chaetomiaceae) from soils in the Bonin Islands, Japan. Mycoscience. 2012;53:312–8.

    Article  Google Scholar 

  11. Altschul SF, et al. Gapped BLAST and PSI-BLAST: a new generation of protein database search programs. Nucl Acids Res. 1997;25:3389–402.

    Article  PubMed  PubMed Central  CAS  Google Scholar 

  12. Phukhamsakda C, et al. Microfungi associated with Clematis (Ranunculaceae) with an integrated approach to delimiting species boundaries. Fungal Divers. 2020;102:1–203.

    Article  Google Scholar 

  13. Clinical and Laboratory Standards Institute (CLSI). M100 performance standards for antimicrobial susceptibility testing, 32nd ed. 2022. Available from: https://clsi.org.

  14. Leber AL, et al. Clinical microbiology procedures handbook, Vol. 1–3, 4th ed. Washington, DC: ASM Press; 2016.

  15. Spencer P, Agnelli F, Sulikowski GA. Investigations into the production and interconversion of phomoidrides A–D. Org Lett. 2001;3:1443–45.

    Article  PubMed  CAS  Google Scholar 

  16. Zhang L, Wang Y, Zhang L, Bingyu L, Chen Z, Daojiang Y, et al. Phomoidrides E-G, three dimeric anhydrides from the fungus Pleosporales sp. give new insight to the biosynthesis of phomoidrides. Org Chem Front. 2021;8:5926–33.

    Article  CAS  Google Scholar 

Download references

Acknowledgements

We are grateful to Distinguished Emeritus Professor Satoshi Ōmura (Kitasato University) for his helpful support and valuable suggestions. Further, we are grateful to Dr. K. Nagai, R. Seki, and N. Sato, School of Pharmacy, Kitasato University for the measurements of mass and NMR spectra. Also, we are grateful to Dr. K. Furuya for isolation of the fungal strain. This study was partially supported by the Platform Project for Supporting Drug Discovery and Life Science Research (Basis for Supporting Innovative Drug Discovery and Life Science Research (BINDS), the Japan Agency for Medical Research & Development (AMED) under Grant Number JP21am0101096 and JP22ama121035. This research was also supported by AMED under Grant Number JP17ak0101053.

Author information

Authors and Affiliations

Authors

Corresponding authors

Correspondence to Yukihiro Asami or Toshiaki Sunazuka.

Ethics declarations

Conflict of interest

The authors declare no competing interests.

Additional information

Publisher’s note Springer Nature remains neutral with regard to jurisdictional claims in published maps and institutional affiliations.

Supplementary information

Rights and permissions

Reprints and permissions

About this article

Check for updates. Verify currency and authenticity via CrossMark

Cite this article

Honsho, M., Kimishima, A., Ikeda, A. et al. The potentiation activity of β-lactam by phomoidrides and oxasetin against methicillin-resistant Staphylococcus aureus. J Antibiot 77, 185–188 (2024). https://doi.org/10.1038/s41429-023-00691-2

Download citation

  • Received:

  • Revised:

  • Accepted:

  • Published:

  • Issue Date:

  • DOI: https://doi.org/10.1038/s41429-023-00691-2

Search

Quick links